Karin de Visser YouTube
Karin E. de Visser Nature Reviews Cancer 16 , 431-446 ( 2016) Cite this article 34k Accesses 1045 Citations 21 Altmetric Metrics Key Points In patients with solid cancers, neutrophils expand.
Projectleider Karin Visser vertelt hoe de regio Amsterdam de subsidieaanvraag aanpakt Babyconnect
KARIN DE VISSER OUR RESOURCES Resources. Our team has developed a preclinical mouse model of invasive lobular breast cancer metastasis. We used this model to unravel mammary tumor-induced pro-metastatic inflammation (IL-17-producing γδ T cells and.
Karin Visser directeur Toezicht en Opsporing bij ILT Nieuwsbericht Algemene Bestuursdienst
Karin E de Visser Netherlands Cancer Institute · Division of Immunology PhD Connect with experts in your field Join ResearchGate to contact this researcher and connect with your scientific.
Karin de Visser, kunstenaar van de maand augustus 2021 » Art & Jazz
Karina Elizabeth de Visser (Karin de Visser, 1975), [1] also named "Karin E. de Visser", is a researcher at the Netherlands Cancer Institute. Her research considers metastatic formation and how the immune system influences how people respond to cancer treatment. Early life and education
Birgit Speulman Karin de Visser Birgit Speulman
Karin de Visser Professor by special appointment Tumor Immunology Name Prof.dr. K.E. de Visser E-mail [email protected] Overview Profile Contact Publications Ancillary activities
Oratie Karin de Visser ‘Het immuunsysteem is een tweesnijdend zwaard’
Seth B Coffelt 1 , Max D Wellenstein 1 , Karin E de Visser 1 Affiliation 1 Division of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. PMID: 27282249 DOI: 10.1038/nrc.2016.52 Abstract Neutrophils are indispensable antagonists of microbial infection and facilitators of wound healing..
De Visser, Karin, PhD TRR332 neutrophils
Bekijk het profiel van Karin de Visser op LinkedIn, de grootste professionele community ter wereld. Karin heeft 7 functies op zijn of haar profiel. Bekijk het volledige profiel op LinkedIn om de connecties van Karin en vacatures bij vergelijkbare bedrijven te zien.
exto.nl City Blues van Karin de Visser
KARIN DE VISSER Karin de Visser Group leader +31 20 512 6104 [email protected] Prof. dr. Karin E. de Visser obtained her PhD at the Division of Immunology at the Netherlands Cancer Institute in Amsterdam in the field of tumor immunotherapy.
exto.nl Encagement met Don Satijn1 van Karin de Visser
615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404 USA Telephone: Email: Karin E. de Visser is a member of the Tumor Microenvironment Working Group Steering Committee.
Rotterdam Contemporary Art Fair 2017
Hannah Garner 1 , Karin E de Visser 2 3 Affiliations 1 Division of Tumour Biology & Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands.. Leiden University Medical Centre, Leiden, Netherlands. [email protected]. PMID: 32024984 DOI: 10.1038/s41577-019-0271-z Abstract.
Effectieve immunotherapie tegen borstkanker KWF Kankerbestrijding
Karin E. de Visser Johanna A. Joyce DOI: https://doi.org/10.1016/j.ccell.2023.02.016 The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth Summary Cancers represent complex ecosystems comprising tumor cells and a multitude of non-cancerous cells, embedded in an altered extracellular matrix.
Inaugural lecture Karin de Visser Oncode Institute
Karin de Visser Inflammation and cancer Metastasis formation and unresponsiveness to conventional therapies are the challenges in cancer patient care that urgently need solutions. The overall goal of our research is to gain novel mechanistic insights into how the immune system influences these processes, with a primary focus on breast cancer.
Karin Karin Visser
Prof. dr. Karin E. de Visser is group leader at the Division of Tumor Biology & Immunology at the Netherlands Cancer Institute, alongside her appointment as group leader at Oncode Institute and as full professor of Experimental Immunobiology of Cancer at Leiden University. The overall goal of her research is to dissect how the immune system influences metastatic breast cancer.
Karin de Visser Suspension
Seth B Coffelt 1 , Karin E de Visser 1 Affiliation 1 Division of Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. PMID: 24572360 DOI: 10.1038/nature13062 No abstract available. Publication types Comment MeSH terms.
Karin De Visser, Working On Threat Famous artists, Artist at work, Studio
Karin E de Visser 1 , Johanna A Joyce 2 Affiliations 1 Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands. Electronic address: [email protected].
Karin de Visser Twentyfour Seven
Karin E. de Visser Nature Reviews Immunology 20 , 483-497 ( 2020) Cite this article 20k Accesses 205 Citations 108 Altmetric Metrics Abstract Metastatic disease is responsible for.
